Atos multiplies supercomputing capacity by 12 at CESGA in Spain with new “Finisterrae III”
Santiago de Compostela (Galicia, Spain), Paris (France) July 29, 2021 Atos has been selected by the Galician Supercomputing Center (CESGA),...
III
Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment
CEO Neil Clark said: "We have made significant progress since closing the £10.4mln equity funding in December 2020 that enabled...
